Diagnostic accuracy of traditional and deep learning methods for detecting depression based on speech features: a systematic review and meta-analysis

基于语音特征的传统方法和深度学习方法在抑郁症检测中的诊断准确性:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Depression diagnosis faces challenges of subjectivity and delay. Speech features offer potential objective biomarkers, but a systematic comparison of traditional machine learning (TML) and deep learning (DL) models is lacking. OBJECTIVE: To evaluate and compare the diagnostic accuracy of TML and DL models for depression detection using speech features, and to examine subgroup effects across sample size, validation strategy, language, and diagnostic criteria. METHODS: Following PRISMA guidelines, we systematically searched 9 databases (PubMed, Medline, Embase, PsycINFO, Scopus, IEEE, Cochrane, ACM Digital Library, and Web of Science) from inception to April 2025. Eligible studies included clinically diagnosed patients with depression and healthy controls, assessed using speech-based TML or DL models, and reporting sensitivity, specificity, or the area under the curve (AUC). Risk of bias was evaluated using the diagnostic Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Random-effects bivariate models pooled diagnostic performance, and heterogeneity, subgroup, and sensitivity analyses were conducted. RESULTS: Twenty-five studies met the inclusion criteria (9 TML, 16 DL). TML models showed pooled sensitivity of 0.82 (95% CI: 0.74-0.88), specificity 0.83 (95% CI: 0.75-0.90), and AUC 0.89 (95% CI: 0.86-0.92). DL models achieved pooled sensitivity of 0.83 (95% CI: 0.77-0.88), specificity 0.86 (95% CI: 0.80-0.90), and AUC 0.91 (95% CI: 0.89-0.93). Subgroup analyses indicated that diagnostic performance varied by sample size, validation strategy, language, and diagnostic criteria. CONCLUSION: Both TML and DL models demonstrate good diagnostic accuracy in speech-based depression detection. ​The marginal but consistent superiority of DL models supports their potential use in secondary care settings for confirmatory diagnosis, while TML remains valuable for primary care screening.​​. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。